ES2196676T3 - Nuevos derivados de arabinosiladenina. - Google Patents

Nuevos derivados de arabinosiladenina.

Info

Publication number
ES2196676T3
ES2196676T3 ES99111945T ES99111945T ES2196676T3 ES 2196676 T3 ES2196676 T3 ES 2196676T3 ES 99111945 T ES99111945 T ES 99111945T ES 99111945 T ES99111945 T ES 99111945T ES 2196676 T3 ES2196676 T3 ES 2196676T3
Authority
ES
Spain
Prior art keywords
virus
ara
present
ada
metabolism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99111945T
Other languages
English (en)
Inventor
Toshio Yamada
Koichi Yamanishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2196676T3 publication Critical patent/ES2196676T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

EL OBJETO DE LA PRESENTE INVENCION ES OBTENER UN DERIVADO PARA - A CON UNA RESISTENCIA AL METABOLISMO MEDIANTE ADA Y UNA ACCION ANTIVIRAL SUFICIENTE. UN NUEVO DERIVADO DE PARABINOSILADENINA 2 - SUSTITUIDA REPRESENTADO POR LA FORMULA (I) Y LAS SALES FARMACEUTICAMENTE ACEPTABLES E HIDRATOS DEL MISMO. [EN LA FORMULA, Z ES ALQUILO QUE TIENE MAS DE 4 ATOMOS DE CARBONO, ALQUENILO O ALQUINILO Y R ES HIDROGENO O ALQUILO INFERIOR]. LOS COMPUESTOS DE LA PRESENTE INVENCION SON DERIVADOS PARA - A CON UNA RESISTENCIA AL METABOLISMO MEDIANTE ADA Y UNA ACCION ANTIVIRAL SUFICIENTE CON LO QUE SE RESUELVEN LOS PROBLEMAS ENCONTRADOS HASTA LA FECHA. LOS COMPUESTOS DE LA PRESENTE INVENCION SON UTILES COMO AGENTES TERAPEUTICOS O PREVENTIVOS PPARA ENFERMEDADES INFECTADAS POR UN VIRUS ADN TALES COMO EL VIRUS DEL HERPES SIMPLE (HSV), HERPESVIRUS, CITOMEGALOVIRUS (CMV), ADENOVIRUS, VIRUS DE LA HEPATITIS O VIRUS DE LA VIRUELA. EN COMPPARACION CON PARA - A, NO SOLO MUESTRAN UN BUEN COMPORTAMIENTO EN SANGRE CON UNA PROPIEDAD DE SUSTENTACION EXCELENTE SINO QUE TAMBIEN SON CAPACES DE SER ADMISTRADOS POR VIA ORAL CON LO QUE SU UTILIDAD ES MUY ALTA.
ES99111945T 1998-06-24 1999-06-23 Nuevos derivados de arabinosiladenina. Expired - Lifetime ES2196676T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17720998A JP3619017B2 (ja) 1998-06-24 1998-06-24 新規アラビノシルアデニン誘導体

Publications (1)

Publication Number Publication Date
ES2196676T3 true ES2196676T3 (es) 2003-12-16

Family

ID=16027087

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99111945T Expired - Lifetime ES2196676T3 (es) 1998-06-24 1999-06-23 Nuevos derivados de arabinosiladenina.

Country Status (9)

Country Link
US (1) US6242429B1 (es)
EP (1) EP0967220B1 (es)
JP (1) JP3619017B2 (es)
KR (1) KR100624050B1 (es)
CN (1) CN1146573C (es)
AT (1) ATE236923T1 (es)
DE (1) DE69906625T2 (es)
ES (1) ES2196676T3 (es)
TW (1) TW564249B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044763A2 (en) * 1999-02-01 2000-08-03 University Of Virginia Patent Foundation Compositions for treating inflammatory response
EP1420021A1 (en) * 1999-05-25 2004-05-19 The Penn State Research Foundation DNA Methyltransferase inhibitors
JP2003501431A (ja) * 1999-05-25 2003-01-14 ザ ペン ステート リサーチ ファウンデイション Ｄｎａメチル基転移酵素阻害剤
JP4138662B2 (ja) 2002-01-10 2008-08-27 ザ・ペンシルバニア・ステイト・リサーチ・フアウンデイシヨン アルキルジアリールボリネートおよび錯化ジアリールボロン酸を調製するための方法。
CA2486339A1 (en) 2002-05-17 2003-11-27 Neurogen Corporation Substituted ring-fused imidazole derivates: gabaa receptor ligands
KR20040036417A (ko) * 2002-10-25 2004-04-30 정낙신 항암 활성을 갖는 티오뉴클레오시드 유도체 및 이를함유하는 약학적 조성물
WO2006040558A1 (en) * 2004-10-15 2006-04-20 Astrazeneca Ab Substituted adenines and the use thereof
WO2007119624A1 (ja) * 2006-04-13 2007-10-25 National University Corporaton Hokkaido University 抗ヘルペスウイルス活性を有するヌクレオシド誘導体

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5545625A (en) 1978-09-26 1980-03-31 Ajinomoto Co Inc 2-methyl-n6-substituted adenine-arabinoside and its preparation
JPS55160797A (en) * 1979-05-31 1980-12-13 Ajinomoto Co Inc Purine nucleoside derivative
AU575438B2 (en) 1984-10-26 1988-07-28 Warner-Lambert Company N6 - substituted deoxyribose analogues of adenosines
JPS6299395A (ja) 1985-10-25 1987-05-08 Yamasa Shoyu Co Ltd ２−アルキニルアデノシンおよび抗高血圧剤
AU8276187A (en) 1986-10-31 1988-05-25 Warner-Lambert Company Selected n6-substituted adenosines having selective a2 binding activity
US4843066A (en) 1986-11-27 1989-06-27 Nippon Zoki Pharmaceutical Co., Ltd. Novel adenosine derivatives and pharmaceutical composition containing them as an active ingredient
DE3739366A1 (de) * 1987-04-10 1988-10-27 Boehringer Mannheim Gmbh Desaza-purin-nucleosid-derivate, verfahren zu deren herstellung sowie deren verwendung bei der nucleinsaeure-sequenzierung sowie als antivirale mittel
GB8712745D0 (en) 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
GB2226027B (en) 1988-12-13 1992-05-20 Sandoz Ltd Adenosine derivatives,their production and use
JPH0725785B2 (ja) 1989-01-11 1995-03-22 日本臓器製薬株式会社 アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
ES2095960T3 (es) 1990-09-25 1997-03-01 Rhone Poulenc Rorer Int Compuestos que tienen propiedades antihipertensivas y antiisquemicas.
HUT61567A (en) 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
US5705491A (en) * 1992-10-27 1998-01-06 Nippon Zoki Pharmaceutical Co., Ltd. Adenosine deaminase inhibitor

Also Published As

Publication number Publication date
EP0967220B1 (en) 2003-04-09
ATE236923T1 (de) 2003-04-15
US6242429B1 (en) 2001-06-05
CN1146573C (zh) 2004-04-21
JP3619017B2 (ja) 2005-02-09
KR100624050B1 (ko) 2006-09-19
DE69906625D1 (de) 2003-05-15
EP0967220A1 (en) 1999-12-29
TW564249B (en) 2003-12-01
JP2000007695A (ja) 2000-01-11
DE69906625T2 (de) 2004-02-05
CN1242373A (zh) 2000-01-26
KR20000006339A (ko) 2000-01-25

Similar Documents

Publication Publication Date Title
KR100279953B1 (ko) 항-b형 간염 바이러스제 및 항-사람 면역결핍 바이러스제로서의 l-2',3'-디데옥시 누클레오시드 유사체
CA1314551C (en) Poly-4-aminopyrrole-2-carboxamido derivatives and their use as site specific alkylating agents
KR930019213A (ko) 간염치료에 유용한 1,3-옥사티올란류
ATE68180T1 (de) Morpholinoethylester von mycophenolsaeure und ihre derivate, ihre herstellung und verwendung in pharmazeutische zusammensetzungen.
KR900701815A (ko) 피리미딘 유도체
PL366726A1 (en) 4'-substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
CA2322008A1 (en) 2'-fluoronucleosides
MY128463A (en) 4' substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
KR900003170A (ko) 신규 화합물
ATE116654T1 (de) Carbocyclische nukleoside und nukleotide.
ES2196676T3 (es) Nuevos derivados de arabinosiladenina.
BRPI0413430A (pt) derivados de amida
IL121305A0 (en) Neuraminic acid derivatives and pharmaceutical compositions containing the same
KR930004296A (ko) 신규(2-알킬-3-피리딜)메틸피페라진 유도체
CO5160292A1 (es) Composicion farmaceutica que contiene derivados de 2-tienil- imidazolo[4,5]piridina, util para el tratamiento de infeccio nes virales
ATE109770T1 (de) Derivate der coffeinsäure und pharmazeutische zusammensetzungen, die sie enthalten.
KR910014119A (ko) 항-고혈압 활성을 갖는 티아졸리딘 유도체 및 그의 치료용도
KR860008973A (ko) 2-피롤리돈 유도체
WO2002085358A2 (en) Antiviral agents and methods of treating viral infections
DE69110528T2 (de) Chirale 2-(Phosphonomethoxy)propyl-Guanine als antivirale Agentien.
ES556551A0 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina
KR900012925A (ko) 인돌 유도체
KR890002103A (ko) 피페리딘 유도체, 그의제법 및 도르지발 38
KR900018093A (ko) 2',3'-디데히드로-2',3'-디데옥시뉴클레오사이드류의 전구체
KR910004621A (ko) 신규 화합물